"Who lives? Flu crisis may make us pick"
Yesterday's St. Petersburg Times was the latest publication to run a feature talking about which groups should receive vaccines first in the event of a shortage in the early stages of an avian flu pandemic. It's another of the stories surfacing in response to the Emanuel/Wertheimer piece in Science earlier this month (which we've discussed here and here.)
The story includes the perspectives of Greg Poland, director of the Mayo Clinic Vaccine Research Group and a member of ACIP, Bruce Gellin, director of the National Vaccine Program Office at HHS, and our own Art Caplan.
The story includes the perspectives of Greg Poland, director of the Mayo Clinic Vaccine Research Group and a member of ACIP, Bruce Gellin, director of the National Vaccine Program Office at HHS, and our own Art Caplan.
Labels: Allocation, Pandemic flu








